Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Should oral contraceptive pills be available without a prescription? A systematic review of over-the-counter and pharmacy access availability.

Kennedy CE, Yeh PT, Gonsalves L, Jafri H, Gaffield ME, Kiarie J, Narasimhan ML.

BMJ Glob Health. 2019 Jun 25;4(3):e001402. doi: 10.1136/bmjgh-2019-001402. eCollection 2019.

2.

Post-partum family planning in Burkina Faso (Yam Daabo): a two group, multi-intervention, single-blinded, cluster-randomised controlled trial.

Tran NT, Seuc A, Coulibaly A, Landoulsi S, Millogo T, Sissoko F, Yameogo WME, Zan S, Cuzin-Kihl A, Kiarie J, Gaffield ME, Thieba B, Kouanda S.

Lancet Glob Health. 2019 Aug;7(8):e1109-e1117. doi: 10.1016/S2214-109X(19)30202-5.

3.

Contraception values and preferences: protocol and methods for a global systematic review.

Kennedy CE, Yeh PT, Gaffield ME.

Contraception. 2019 Jun 4. pii: S0010-7824(18)30182-3. doi: 10.1016/j.contraception.2018.05.006. [Epub ahead of print]

PMID:
31173733
4.

Follow-up visits to check strings after intrauterine contraceptive placement cannot predict or prevent future expulsion.

Bahamondes L, Monteiro I, Fernandes A, Gaffield ME.

Eur J Contracept Reprod Health Care. 2019 Apr;24(2):97-101. doi: 10.1080/13625187.2019.1586872. Epub 2019 Mar 14.

PMID:
30870042
5.

Postpartum family-planning barriers and catalysts in Burkina Faso and the Democratic Republic of Congo: a multiperspective study.

Tran NT, Yameogo WME, Gaffield ME, Langwana F, Kiarie J, Kulimba DM, Kouanda S.

Open Access J Contracept. 2018 Nov 9;9:63-74. doi: 10.2147/OAJC.S170150. eCollection 2018.

6.

Birth spacing and informed family planning choices after childbirth in Burkina Faso and the Democratic Republic of Congo: Participatory action research to design and evaluate a decision-making tool for providers and their clients.

Tran NT, Yameogo WMM, Langwana F, Kouanda S, Thieba B, Mashinda D, Yodi R, Nyandwe Kyloka J, Millogo T, Coulibaly A, Zan S, Kini B, Ouedraogo B, Puludisi F, Cuzin-Kihl A, Reier S, Kiarie J, Gaffield ME.

Patient Educ Couns. 2018 Oct;101(10):1871-1875. doi: 10.1016/j.pec.2018.05.004. Epub 2018 May 2.

PMID:
30001823
7.

Participatory action research to identify a package of interventions to promote postpartum family planning in Burkina Faso and the Democratic Republic of Congo.

Tran NT, Yameogo WME, Langwana F, Gaffield ME, Seuc A, Cuzin-Kihl A, Kouanda S, Mashinda D, Thieba B, Yodi R, Nyandwe Kyloka J, Millogo T, Coulibaly A, Bolangala B, Zan S, Kini B, Ouedraogo B, Puludisi F, Landoulsi S, Kiarie J, Reier S.

BMC Womens Health. 2018 Jul 5;18(1):122. doi: 10.1186/s12905-018-0573-5.

8.

Effectiveness of a package of postpartum family planning interventions on the uptake of contraceptive methods until twelve months postpartum in Burkina Faso and the Democratic Republic of Congo: the YAM DAABO study protocol.

Tran NT, Gaffield ME, Seuc A, Landoulsi S, Yamaego WME, Cuzin-Kihl A, Kouanda S, Thieba B, Mashinda D, Yodi R, Kiarie J, Reier S.

BMC Health Serv Res. 2018 Jun 11;18(1):439. doi: 10.1186/s12913-018-3199-2.

9.

Dissemination and use of WHO family planning guidance and tools: a qualitative assessment.

Kraft JM, Oduyebo T, Jatlaoui TC, Curtis KM, Whiteman MK, Zapata LB, Gaffield ME.

Health Res Policy Syst. 2018 May 22;16(1):42. doi: 10.1186/s12961-018-0321-1.

10.

A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.

Dragoman MV, Tepper NK, Fu R, Curtis KM, Chou R, Gaffield ME.

Int J Gynaecol Obstet. 2018 Jun;141(3):287-294. doi: 10.1002/ijgo.12455. Epub 2018 Feb 22. Review.

11.

Re-Evaluating the Possible Increased Risk of HIV Acquisition With Progestin-Only Injectables Versus Maternal Mortality and Life Expectancy in Africa: A Decision Analysis.

Rodriguez MI, Gaffield ME, Han L, Caughey AB.

Glob Health Sci Pract. 2017 Dec 28;5(4):581-591. doi: 10.9745/GHSP-D-17-00243. Print 2017 Dec 28.

12.

Development, updates, and future directions of the World Health Organization Selected Practice Recommendations for Contraceptive Use.

Chen MJ, Kim CR, Whitehouse KC, Berry-Bibee E, Gaffield ME.

Int J Gynaecol Obstet. 2017 Feb;136(2):113-119. doi: 10.1002/ijgo.12064. Epub 2016 Dec 13. No abstract available.

13.

Introducing the World Health Organization Postpartum Family Planning Compendium.

Sonalkar S, Gaffield ME.

Int J Gynaecol Obstet. 2017 Jan;136(1):2-5. doi: 10.1002/ijgo.12003. Epub 2016 Nov 3.

14.

Drug interactions between hormonal contraceptives and antiretrovirals.

Nanda K, Stuart GS, Robinson J, Gray AL, Tepper NK, Gaffield ME.

AIDS. 2017 Apr 24;31(7):917-952. doi: 10.1097/QAD.0000000000001392. Review.

15.

Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.

Tepper NK, Dragoman MV, Gaffield ME, Curtis KM.

Contraception. 2017 Feb;95(2):130-139. doi: 10.1016/j.contraception.2016.10.005. Epub 2016 Oct 19. Review.

PMID:
27771476
16.

Use of the World Health Organization's Medical Eligibility Criteria for Contraceptive Use Guidance in sub-Saharan African Countries: A Cross-Sectional Study.

Chen MJ, Gaffield ME, Kiarie J.

Glob Health Sci Pract. 2016 Sep 29;4(3):506-10. doi: 10.9745/GHSP-D-16-00216. Print 2016 Sep 28.

17.

The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review.

Dragoman MV, Gaffield ME.

Contraception. 2016 Sep;94(3):202-15. doi: 10.1016/j.contraception.2016.02.003. Epub 2016 Feb 10. Review.

18.

Research gaps identified during the 2014 update of the WHO medical eligibility criteria for contraceptive use and selected practice recommendations for contraceptive use.

Dragoman MV, Jatlaoui T, Nanda K, Curtis KM, Gaffield ME.

Contraception. 2016 Sep;94(3):195-201. doi: 10.1016/j.contraception.2015.12.009. Epub 2015 Dec 23. Review. No abstract available.

19.

The WHO's medical eligibility criteria for contraceptive use: 20 years of global guidance.

Altshuler AL, Gaffield ME, Kiarie JN.

Curr Opin Obstet Gynecol. 2015 Dec;27(6):451-9. doi: 10.1097/GCO.0000000000000212. Review.

20.

Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.

Dragoman M, Curtis KM, Gaffield ME.

Contraception. 2016 Sep;94(3):280-7. doi: 10.1016/j.contraception.2015.08.002. Epub 2015 Aug 10. Review.

21.

Combined hormonal contraceptive use among breastfeeding women: an updated systematic review.

Tepper NK, Phillips SJ, Kapp N, Gaffield ME, Curtis KM.

Contraception. 2016 Sep;94(3):262-74. doi: 10.1016/j.contraception.2015.05.006. Epub 2015 May 19. Review.

22.

Safety of the progesterone-releasing vaginal ring (PVR) among lactating women: A systematic review.

Carr SL, Gaffield ME, Dragoman MV, Phillips S.

Contraception. 2016 Sep;94(3):253-61. doi: 10.1016/j.contraception.2015.04.001. Epub 2015 Apr 11. Review.

23.

It's about time: WHO and partners release programming strategies for postpartum family planning.

Gaffield ME, Egan S, Temmerman M.

Glob Health Sci Pract. 2014 Feb 4;2(1):4-9. doi: 10.9745/GHSP-D-13-00156. eCollection 2014 Feb. Review.

24.

Outreach and integration programs to promote family planning in the extended postpartum period.

Sonalkar S, Mody S, Gaffield ME.

Int J Gynaecol Obstet. 2014 Mar;124(3):193-7. doi: 10.1016/j.ijgo.2013.09.021. Epub 2013 Dec 12. Review.

25.
26.

The World Health Organization-United Nations Population Fund Strategic Partnership Programme's implementation of family planning guidelines and tools in Asia-Pacific countries.

Mody SK, Ba-Thike K, Gaffield ME.

J Obstet Gynaecol Res. 2013 Apr;39(4):825-30. doi: 10.1111/j.1447-0756.2012.02046.x. Epub 2012 Nov 20.

PMID:
23167754
27.

Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review.

Tepper NK, Steenland MW, Gaffield ME, Marchbanks PA, Curtis KM.

Contraception. 2013 May;87(5):655-60. doi: 10.1016/j.contraception.2012.08.011. Epub 2012 Oct 4. Review.

PMID:
23040135
28.

Initiation of progestogen-only injectables on different days of the menstrual cycle and its effect on contraceptive effectiveness and compliance: a systematic review.

Kapp N, Gaffield ME.

Contraception. 2013 May;87(5):576-82. doi: 10.1016/j.contraception.2012.08.017. Epub 2012 Sep 17. Review.

PMID:
22995541
29.

When can a woman have an intrauterine device inserted? A systematic review.

Whiteman MK, Tyler CP, Folger SG, Gaffield ME, Curtis KM.

Contraception. 2013 May;87(5):666-73. doi: 10.1016/j.contraception.2012.08.015. Epub 2012 Sep 17. Review.

30.

Pregnancy outcomes with an IUD in situ: a systematic review.

Brahmi D, Steenland MW, Renner RM, Gaffield ME, Curtis KM.

Contraception. 2012 Feb;85(2):131-9. doi: 10.1016/j.contraception.2011.06.010. Epub 2011 Aug 16. Review.

PMID:
22067777
31.

Risk of venous thromboembolism during the postpartum period: a systematic review.

Jackson E, Curtis KM, Gaffield ME.

Obstet Gynecol. 2011 Mar;117(3):691-703. doi: 10.1097/AOG.0b013e31820ce2db. Review.

PMID:
21343773
32.

The use of hormonal contraception among women taking anticonvulsant therapy.

Gaffield ME, Culwell KR, Lee CR.

Contraception. 2011 Jan;83(1):16-29. doi: 10.1016/j.contraception.2010.06.013. Epub 2010 Sep 15. Review.

PMID:
21134499
33.

Guidance on medical eligibility criteria for contraceptive use: identification of research gaps.

Folger SG, Curtis KM, Tepper NK, Gaffield ME, Marchbanks PA.

Contraception. 2010 Jul;82(1):113-8. doi: 10.1016/j.contraception.2010.02.015. Epub 2010 Mar 31. No abstract available.

PMID:
20682149
34.

Oral contraceptives and family history of breast cancer.

Gaffield ME, Culwell KR, Ravi A.

Contraception. 2009 Oct;80(4):372-80. doi: 10.1016/j.contraception.2009.04.010. Epub 2009 Jun 10. Review.

PMID:
19751860
35.

Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease.

Gaffield ME, Kapp N, Curtis KM.

Contraception. 2009 Oct;80(4):363-71. doi: 10.1016/j.contraception.2009.03.022. Epub 2009 Jun 4. Review.

PMID:
19751859
36.

Use of combined oral contraceptives post abortion.

Gaffield ME, Kapp N, Ravi A.

Contraception. 2009 Oct;80(4):355-62. doi: 10.1016/j.contraception.2009.04.005. Epub 2009 Jun 4. Review.

PMID:
19751858
37.

Medical eligibility criteria for new contraceptive methods: combined hormonal patch, combined hormonal vaginal ring and the etonogestrel implant.

Gaffield ME, Curtis KM, Mohllajee AP, Peterson HB.

Contraception. 2006 Feb;73(2):134-44. Epub 2005 Oct 20. Review.

PMID:
16413844
38.

Effective use of hormonal contraceptives: Part II: Combined hormonal injectables, progestogen-only injectables and contraceptive implants.

Chrisman CE, Curtis KM, Mohllajee AP, Gaffield ME, Peterson HB.

Contraception. 2006 Feb;73(2):125-33. Epub 2005 Oct 21. Review.

PMID:
16413843
39.

Social structure, race, and gonorrhea rates in the southeastern United States.

Thomas JC, Gaffield ME.

Ethn Dis. 2003 Summer;13(3):362-8.

PMID:
12894961
40.

Prevalence of selected maternal behaviors and experiences, Pregnancy Risk Assessment Monitoring System (PRAMS), 1999.

Beck LF, Morrow B, Lipscomb LE, Johnson CH, Gaffield ME, Rogers M, Gilbert BC.

MMWR Surveill Summ. 2002 Apr 26;51(2):1-27.

41.

Prevalence of selected maternal and infant characteristics, Pregnancy Risk Assessment Monitoring System (PRAMS), 1997.

Colley Gilbert BJ, Johnson CH, Morrow B, Gaffield ME, Ahluwalia I.

MMWR CDC Surveill Summ. 1999 Sep 24;48(5):1-37.

PMID:
10507247

Supplemental Content

Loading ...
Support Center